ArticleJournal of nanobiotechnology2026
Diameter-dependent effects of nanopillar arrays on PEEK bioactivity and soft tissue integration.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Poly-Ether-Ether-Ketone (PEEK) is a promising material for bony structure defects reconstruction due to its favorable mechanical properties and radiolucency. However, its clinical application is limited by poor soft tissue integration resulting from surface bio-inertness. In this study, a highly uniform Nanopillar Array PEEK (NAP) was fabricated using an anodic aluminum oxide (AAO) template-based melt-casting method. The resulting nanostructures exhibited precise control over nanopillar diameter (100-300 nm) without detectable chemical alterations. In vitro experiments demonstrated that NAP significantly enhanced fibroblast adhesion, proliferation, and collagen secretion, with efficacy positively correlating to nanopillar diameters. In the in vivo chest wall implantation model, NAP promoted superior soft tissue integration, as evidenced by increased collagen deposition and elevated expression of integrinβ1, fibronectin, COL-1, VEGF, and CTGF. Transcriptome analysis revealed that NAP upregulated Areg and Farp1 genes, which are associated with cytoskeletal reorganization and adhesion signaling, in a diameter-dependent manner. In conclusion, this study establishes a reproducible strategy for tailoring PEEK surface topography to enhance bioactivity and provides insights into the design of advanced implants for soft tissue integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.